Proacta Company

Proacta is a clinical-stage biopharmaceutical company developing hypoxia-activated ’prodrugs“ for the treatment of cancer.
Technology: Others
Industry: PharmTech
Headquarters: La Jolla, California, United States
Founded Date: 2004
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 7
Total Funding: $47M
Last Funding Type: Debt Financing

Visit Website
Register and Claim Ownership